Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Emily Risa Schwartz"'
Autor:
C. Michel Zwaan, Rutger R. G. Knops, Gertjan J.L. Kaspers, Raphaële R. L. van Litsenburg, Wim J. E. Tissing, Birgitta Versluijs, Natasja Dors, Marry M. van den Heuvel-Eibrink, Kim Klein, Valerie de Haas, Emily Risa Schwartz
Publikováno v:
Blood. 138:2293-2293
Introduction Together with considerable improvement in diagnostics and supportive care measures, treatment intensification has contributed to the improvement of pediatric acute myeloid leukemia (AML) survival outcomes. However, treatment-related toxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6afa983327cdf9d64276639736859614
https://doi.org/10.1182/blood-2021-149851
https://doi.org/10.1182/blood-2021-149851
Autor:
Valerie de Haas, Wim J. E. Tissing, Christian M. Zwaan, Gertjan J.L. Kaspers, Lynn Ball, Kim Klein, Birgit I. Lissenberg-Witte, Birgitta Versluys, Raphaële R. L. van Litsenburg, Rutger R. G. Knops, Marry M. van den Heuvel-Eibrink, Natasja Dors, Emily Risa Schwartz
Publikováno v:
Blood. 132:2685-2685
Background/Objectives Despite the use of antibiotic prophylaxis, bacterial infections remain the leading cause of treatment-related morbidity in children with acute myeloid leukemia (AML). The objectives of this study were to: 1) evaluate the cumulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bae10f34321d5360c033ee780a31762
https://doi.org/10.1182/blood-2018-99-114364
https://doi.org/10.1182/blood-2018-99-114364